New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases-Reference-Cited by-同舟云学术

New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases

Published:2016-06-13 Issue:1 Volume:31 Page:181-186
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Méry-Bossard L.¹,Bagny K.²,Chaby G.³,Khemis A.⁴,Maccari F.⁵,Marotte H.⁶,Perrot J.L.⁷,Reguiai Z.⁸,Sigal M.L.⁹,Avenel-Audran M.¹⁰,Boyé T.¹¹,Grasland A.¹²,Gillard J.¹³,Jullien D.¹⁴,Toussirot E.¹⁵

Affiliation:

1. Département de dermatologie; CH François Quesnay; Mantes-la-Jolie France

2. Département de médecine interne et dermatologie; CHU Felix Guyon; Saint-Denis France

3. Département de dermatologie; CHU Amiens Picardie Site Nord; Amiens France

4. Département de dermatologie; CHU Archet 2; Nice France

5. Département de dermatologie; HIA Bégin; Saint-Mandé France

6. Département de rhumatologie; CHU Saint-Etienne Hôpital Nord; Saint Etienne France

7. Département de dermatologie; CHU Saint Etienne Hôpital Nord; Saint-Etienne France

8. Département de dermatologie; CHU Reims; Reims France

9. Département de dermatologie; CH Victor Dupouy; Argenteuil France

10. Département de dermatologie; CHU Angers; Angers France

11. Département de dermatologie; HIA Sainte-Anne; Toulon France

12. Département de médecine interne; AP-HP Hôpital Louis Mourier; Colombes France

13. Département de rhumatologie; CHT Jura Sud; Lons le Saulnier France

14. Département de Dermatologie; CHU Edouard Herriot; Lyon France

15. Centre d'investigation clinique biothérapie INSERM CIC-1431; FHU INCREASE; Rhumatologie; CHRU; Besançon France

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.13759/fullpdf

Reference33 articles.

1. Cutaneous events during anti-TNF alpha therapy: a prospective observational study of 41 cases;Bonnet;Ann Dermatol Venereol,2010

2. The skin tissue is adversely affected by TNF-alpha blockers in patients with chronic inflammatory arthritis: a 5-year prospective analysis;Machado;Clinics (Sao Paulo),2013

3. Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review;Moustou;J Am Acad Dermatol,2009

4. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis;Collamer;Semin Arthritis Rheum,2010

5. Clinical practice: vitiligo;Taïeb;N Engl J Med,2009

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Regulatory Cell Death in Vitiligo;DNA and Cell Biology;2023-12-28

2. Updates on Potential Therapeutic Approaches for Vitiligo: Janus Kinase Inhibitors and Biologics;Journal of Clinical Medicine;2023-12-04

3. Cutaneous immune-related phenomena in patients with inflammatory arthritides treated with biological therapies: Clinical and pathophysiological considerations;Seminars in Arthritis and Rheumatism;2023-12

4. New-onset vitiligo during treatment with golimumab;Annales de Dermatologie et de Vénéréologie;2023-09

5. Vitiligo. Novel Treatment Modalities. Small Molecule Inhibitors and Cytokine-Targeted Treatments;J BIOL REG HOMEOS AG;2023